Chemoinformaics analysis of Ethyl geranyl ether
| Molecular Weight | 182.307 | nRot | 6 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 2 |
| Exact Molecular Weight | 182.167 | nRing | 0 |
| Solubility: LogS | -4.136 | nHRing | 0 |
| Solubility: LogP | 4.151 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.5114 |
| nHD | 0 | BPOL | 23.8066 |
| QED | 0.449 |
| Synth | 2.64 |
| Natural Product Likeliness | 2.048 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.816 |
| Pgp-sub | 0.005 |
| HIA | 0.004 |
| CACO-2 | -4.437 |
| MDCK | 0.000025 |
| BBB | 0.794 |
| PPB | 0.968152 |
| VDSS | 1.861 |
| FU | 0.0373095 |
| CYP1A2-inh | 0.789 |
| CYP1A2-sub | 0.231 |
| CYP2c19-inh | 0.426 |
| CYP2c19-sub | 0.656 |
| CYP2c9-inh | 0.184 |
| CYP2c9-sub | 0.199 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.051 |
| CYP3a4-sub | 0.226 |
| CL | 9.173 |
| T12 | 0.439 |
| hERG | 0.016 |
| Ames | 0.002 |
| ROA | 0.005 |
| SkinSen | 0.929 |
| Carcinogencity | 0.058 |
| EI | 0.912 |
| Respiratory | 0.012 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.634579 |